Counde O-Yang

1.3k total citations
22 papers, 649 citations indexed

About

Counde O-Yang is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Counde O-Yang has authored 22 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Pharmaceutical Science. Recurrent topics in Counde O-Yang's work include Synthetic Organic Chemistry Methods (4 papers), Fluorine in Organic Chemistry (4 papers) and Epigenetics and DNA Methylation (3 papers). Counde O-Yang is often cited by papers focused on Synthetic Organic Chemistry Methods (4 papers), Fluorine in Organic Chemistry (4 papers) and Epigenetics and DNA Methylation (3 papers). Counde O-Yang collaborates with scholars based in United States, Poland and China. Counde O-Yang's co-authors include Keith A. M. Walker, Helen Y. Wu, Francis Barth, E B Fraser-Smith, Anthony Ford, Joel R. Gever, Lilia J. Kurz, Elsie M. Eugui, Mary Frances Jett and Julien P. H. Verheyden and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Counde O-Yang

22 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Counde O-Yang United States 13 311 266 117 94 69 22 649
Pauline C. Ting United States 18 300 1.0× 449 1.7× 28 0.2× 77 0.8× 27 0.4× 42 931
Arnold van Loevezijn Netherlands 10 445 1.4× 186 0.7× 132 1.1× 98 1.0× 19 0.3× 11 986
J. Romine United States 19 362 1.2× 441 1.7× 143 1.2× 78 0.8× 23 0.3× 31 1.0k
Richard A. Nugent United States 15 289 0.9× 356 1.3× 80 0.7× 312 3.3× 15 0.2× 26 897
Eric E. Boros United States 16 473 1.5× 283 1.1× 59 0.5× 27 0.3× 12 0.2× 36 840
Ying K. Yee United States 16 275 0.9× 291 1.1× 22 0.2× 95 1.0× 20 0.3× 24 885
Dennis A. Shuman United States 13 453 1.5× 194 0.7× 70 0.6× 26 0.3× 15 0.2× 18 623
L. А. Alexandrova Russia 12 325 1.0× 137 0.5× 117 1.0× 26 0.3× 14 0.2× 43 583
Robert J. Weikert United States 13 247 0.8× 293 1.1× 26 0.2× 45 0.5× 18 0.3× 17 736
Danny Gauvreau Canada 19 237 0.8× 391 1.5× 15 0.1× 44 0.5× 72 1.0× 31 814

Countries citing papers authored by Counde O-Yang

Since Specialization
Citations

This map shows the geographic impact of Counde O-Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Counde O-Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Counde O-Yang more than expected).

Fields of papers citing papers by Counde O-Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Counde O-Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Counde O-Yang. The network helps show where Counde O-Yang may publish in the future.

Co-authorship network of co-authors of Counde O-Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Counde O-Yang. A scholar is included among the top collaborators of Counde O-Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Counde O-Yang. Counde O-Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiang-Wei, Michael Kiffe, Markus Walles, et al.. (2021). Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment. Xenobiotica. 52(1). 65–78. 7 indexed citations
2.
Senisterra, Guillermo, Hugh Zhu, Xiao Luo, et al.. (2018). Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor Domain. SLAS DISCOVERY. 23(9). 930–940. 28 indexed citations
3.
Yu, Yanyan, Jiajia Chen, Yuan Gao, et al.. (2016). Quantitative Profiling of Combinational K27/K36 Modifications on Histone H3 Variants in Mouse Organs. Journal of Proteome Research. 15(3). 1070–1079. 15 indexed citations
4.
Bunnell, Aaron E., et al.. (2006). Convenient Method for the 3‐Functionalization of Isoindazoles. Synthetic Communications. 36(3). 285–293. 16 indexed citations
5.
Bley, Keith, Anindya Bhattacharya, Joel R. Gever, et al.. (2005). RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists. British Journal of Pharmacology. 147(3). 335–345. 89 indexed citations
6.
Blue, David R., Donald V. Daniels, Joel R. Gever, et al.. (2003). Pharmacological characteristics of Ro 115–1240, a selective α 1A/1L ‐adrenoceptor partial agonist: a potential therapy for stress urinary incontinence. British Journal of Urology. 93(1). 162–170. 33 indexed citations
7.
López, Francisco J., et al.. (2002). ChemInform Abstract: Synthesis and Biological Evaluation of Ketorolac Analogues.. ChemInform. 33(20). 2 indexed citations
8.
López, Francisco J., et al.. (2002). Synthesis and Biological Evaluation of Ketorolac Analogs. Heterocycles. 56(1-2). 91–91. 10 indexed citations
9.
Jett, Mary Frances, C S Ramesha, Clinton D. Brown, et al.. (1999). Characterization of the Analgesic and Anti-Inflammatory Activities of Ketorolac and Its Enantiomers in the Rat. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1288–1297. 77 indexed citations
10.
O-Yang, Counde, et al.. (1995). New Approaches to the Preparation of 1-Substituted 1,3-Dihydroimidazole-2-thione Derivatives: Thionation of Imidazoles1. Synlett. 1995(6). 655–658. 9 indexed citations
11.
O-Yang, Counde, et al.. (1992). 4′-Substituted nucleosides as inhibitors of HIV: an unusual oxetane derivative.. Tetrahedron Letters. 33(1). 41–44. 76 indexed citations
12.
O-Yang, Counde, Helen Y. Wu, E B Fraser-Smith, & Keith A. M. Walker. (1992). Synthesis of 4′-cyanothymidine and analogs as potent inhibitors of HIV.. Tetrahedron Letters. 33(1). 37–40. 111 indexed citations
13.
Barth, Francis & Counde O-Yang. (1991). Cyclization of α,α-Difluoromethyl Radicals: A New Route to the Preparation of Difluorocyclopentane Derivatives. Tetrahedron Letters. 32(42). 5873–5876. 24 indexed citations
14.
Barth, Francis & Counde O-Yang. (1990). Radical cyclizatations of α-fluoro-α-iodo and α-iodo esters and amides.. Tetrahedron Letters. 31(8). 1121–1124. 43 indexed citations
15.
Fried, Josef, Varghese John, Counde O-Yang, et al.. (1989). Synthesis of 10,10-difluorothromboxane A2, a potent and chemically stable thromboxane agonist. Journal of the American Chemical Society. 111(12). 4510–4511. 19 indexed citations
16.
O-Yang, Counde, et al.. (1988). Stability of Prostacyclin Analogues: An Unusual Lack of Reactivity in Acid-Catalyzed Alkene Hydration. Pharmaceutical Research. 5(4). 214–219. 12 indexed citations
17.
Smith, D. Lynne, Carmen Vigo, Arthur F. Kluge, et al.. (1987). Orally active prostacyclin-mimetic RS-93427: therapeutic potential in vascular occlusive disease associated with atherosclerosis.. PubMed. 17A. 254–65. 5 indexed citations
18.
Kluge, Arthur F., D Kertesz, Counde O-Yang, & Helen Y. Wu. (1987). Potent prostacyclin analogs based on the bicyclo[4.2.0]octane ring system. The Journal of Organic Chemistry. 52(13). 2860–2868. 28 indexed citations
19.
O-Yang, Counde & Josef Fried. (1983). Separation of Acetylenic Prostaglandin Isomers as Cobalt Complexes. Tetrahedron Letters. 24(25). 2533–2536. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauline C. Ting Breakdown of academic impact, for papers by Arnold van Loevezijn Breakdown of academic impact, for papers by J. Romine Breakdown of academic impact, for papers by Richard A. Nugent Breakdown of academic impact, for papers by Eric E. Boros Breakdown of academic impact, for papers by Ying K. Yee Breakdown of academic impact, for papers by Dennis A. Shuman Breakdown of academic impact, for papers by L. А. Alexandrova Breakdown of academic impact, for papers by Robert J. Weikert Breakdown of academic impact, for papers by Danny Gauvreau
Rankless by CCL
2026